EQRx is committed to making innovative medicines at dramatically lower prices for the benefit of people and society. By bringing together stakeholders from across the healthcare system and utilizing the latest advances in science and technology, the company seeks to discover, develop and deliver high-quality, patent-protected medicines more efficiently and cost-effectively than ever before.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/14/20 | $200,000,000 | Series A |
Arboretum Ventures ARCH Venture Partners  Casdin Capital GV Nextech Invest Section 32 | undisclosed |
